Siloed data and information put the entire project at risk, which has led to the introduction of policies and standards like ISO 19650. To break free from these siloes, architects, engineers, construction professionals, and project owners must prioritize system integration strategies, improve document management, and deploy operations and maintenance initiatives to avoid risk of noncompliance, lost bids, and financial instability.

Join ProjectReady CEO Joe Giegerich & Lead Developer Shaili Modi Oza as they discuss the challenge AEC firms face today and what's possible in bringing information together across systems to deliver collaborative project information management.

The Art of the Possible - Part 1 - Solving the Challenge of Siloed Data in the AEC

In this episode, Professors Grant Stewart and Stephen Price discuss what it means to be both a cancer surgeon and a clinical researcher. They talk about how they can improve surgery for brain and kidney cancer patients, how they can identify cancer as quickly as possible through screening, and how they can improve on the outcomes of surgery by augmenting it with other treatments such as radiotherapy and drugs.

Grant is co-lead of both the Institute for Integrated Cancer Medicine and the Urological Malignancies Virtual Institute at the CRUK Cambridge Centre, UK, and is Professor of Surgical Oncology in the Department of Surgery at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust.

Stephen is co-lead of the Brain Cancer Virtual Institute at the CRUK Cambridge Centre, UK, and is Professor of Neurosurgical Oncology and Honorary Consultant Neurosurgeon at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust.

Integrated Cancer Medicine: Research in Focus

Surgery and clinical research in cancer

Dr Ines Machado, Dr Gabriel Funingana, Thomas Buddenkotte and Amied Shadmaan talk about the research they are undertaking within the collaborative project between GE Healthcare, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. They also provide an update on the development of the Oncocare platform.

Ines is a Research Associate in the Crispin Lab at the CRUK Cambridge Institute, University of Cambridge, UK.

Gabriel is a Clinical Fellow and PhD student in the Department of Oncology, University of Cambridge, UK.

Thomas is a consultant to the Crispin Lab. He obtained his PhD at the University of Cambridge, UK, working at the Department of Applied Mathematics and Theoretical Physics and the Department of Radiology. He is now affiliated with the Department of Diagnostic and Interventional Radiology and Nuclear Medicine at the University Medical Center Hamburg-Eppendorf, Germany, and the Hamburg-based company Jung Diagnostics.

Amied is Director of AI & Clinical Collaborations at GE Healthcare.

AI in cancer research and an update on the GE Healthcare collaboration

Today's podcast focuses on "Beyond Mobility," Valtech's concept exploring how technological innovations are transforming the automotive industry. Join us as we delve into the impact of electric and autonomous vehicles, connectivity, and data integration.  

Gain insights on the latest trends in mobility as Denny Pezic, Valtech Global Vertical Lead of Mobility & Automotive, sits down with Nissan Head of Global Digital Product and Implementation Viv Yuen and Valtech Strategist Nick Richardson to discuss the role of generative AI and digital transformation.  

For more in-depth information, visit Valtech's website and explore our work on connected mobility.

Experience Innovation Stories: Unlocking Success Beyond Mobility

In this episode, we dive into how SolveBI helps businesses in Perth harness the power of Power BI, data analytics, data visualisation and business intelligence. Learn how we transform raw data into actionable insights, streamline reporting, and drive smarter decision-making. Whether you're a business owner or a data enthusiast, this podcast is your guide to maximizing BI solutions.

SolveBI - Business Intelligence Solutions

Have you ever wondered how artificial intelligence (AI) is used in research in a healthcare setting? Rebecca Wray and Bill McGough, two PhD students at the University of Cambridge, both use AI in different ways in their research into the screening and treatment of kidney cancer.

Rebecca is an MRes PhD student investigating the response and resistance to therapy in patients with kidney cancer. She uses AI to find tumour features at multiple scales. For his PhD, Bill is developing AI models that will sift through the mounds of imaging data produced during the Yorkshire Kidney Screening Trial (funded by Yorkshire Cancer Research), flagging images that show masses in the kidneys.

This interesting conversation gives insight into how researchers are using patient data safely in order for AI models to integrate all the information about a patient to help review their treatment and personalise it. The discussion also highlights how using AI in the screening setting is speeding up processes to help save clinicians' time and allowing the potential earlier detection of kidney cancer in a cost-effective manner.

Using AI in the screening and treatment of kidney cancer

The convergence of technology, design and content. Valtech Café is a hub to share knowledge, explore new industry concepts, to guide and define best practices.
Learn more on www.valtech.com

Valtech Café nous permet de partager des connaissances, d'explorer de nouveaux concepts de l'industrie pour guider et définir les bonnes pratiques.

Modern End-to-End Software as a Service Solution, Delivering Project Management & Document Control in the AEC across SharePoint, Autodesk, Box, Microsoft Teams, Bluebeam and Outlook

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

New tracks tagged #data integration